Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma.

NPJ Precis Oncol · 2026 · PMC12877020 · PMID 41571736

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Our study showed trends towards improved response and PFS in NF1 -mutated patients compared to those with wild-type NF1 , though this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.